School of Medicine
Showing 101-200 of 1,617 Results
-
Thomas Bearrood
Postdoctoral Scholar, Chemical and Systems Biology
BioThomas Bearrood received his B.A. from St. Olaf College, double majoring in chemistry and math. He received his Ph.D. in chemistry from the University of Illinois at Urbana-Champaign. His graduate research was completed in Jeff Chan's lab, where he developed activity-based fluorescent and photoacoustic probes for biologically interesting molecules. Thomas came to Stanford in 2021 as a postdoctoral scholar in James Chen's lab. His current research focuses on understanding the role of ALDH1B1 in gastrointestinal cancers.
-
Vasiliki Bikia
Postdoctoral Scholar, Biomedical Informatics
BioDr. Vasiliki Bikia is a postdoctoral researcher at the Byers Center for Biodesign, Stanford. She received her Advanced Diploma degree in Electrical and Computer Engineering from the Aristotle University of Thessaloniki (AUTH), Greece, in 2017, and her Ph.D. degree in Biomedical Engineering from the Swiss Federal Institute of Technology of Lausanne (EPFL), Switzerland, in 2021. Her Ph.D. research addressed the clinical need for providing non-invasive tools for cardiovascular monitoring leveraging machine learning and physics-based numerical modeling. In particular, she developed and tested novel healthcare algorithms for major biomarkers including central blood pressure, stroke volume, left ventricular elastance and arterial stiffness. At Stanford, she contributes to the Stanford Spezi framework, designing and prototyping the Spezi Data Pipeline tool for enhanced digital health data accessibility and analysis workflows. Her work includes exploring smartwatches for arrhythmia detection in children and integrating physical activity data for personalized care with major pharma companies.
Her research interests include health algorithms, digital biomarkers, machine learning, non-invasive monitoring, and the application of large language models for personalized healthcare, predictive analytics, and enhancing patient-clinician interactions. -
Bernardo Bonilauri
Postdoctoral Scholar, Cardiovascular Institute
BioI am a highly motivated and devoted scientist, deeply committed to advancing our understanding of the molecular foundations of cardiovascular disease while spearheading innovative therapeutic approaches and drug discovery. As a Postdoctoral Research Fellow at the Stanford Cardiovascular Institute, under the guidance of Dr. Joseph C. Wu, I am privileged to contribute to cutting-edge research. My work spans various disciplines, including multi-omics, molecular and cellular biology, tissue engineering, biochemistry, structural biology, and state-of-the-art imaging technologies. This holistic approach and sharp critical thinking equips me to untangle the complexities of cardiac diseases and innovate novel therapeutic strategies, particularly for rare cardiac conditions such as Transthyretin Cardiac Amyloidosis.
-
Molly Bowdring
Clinical Scholar, Psychiatry and Behavioral Sciences
Postdoctoral Scholar, SCRDP/ Heart Disease PreventionCurrent Research and Scholarly InterestsI am interested in elucidating factors that contribute to initiation, maintenance, and exacerbation of substance use, and identifying approaches to mitigate risky use.
I additionally seek to use scholarly advocacy to enhance diversity, equity, and inclusion within clinical and academic spaces. -
Nathaniel Breg
Postdoctoral Scholar, Health Policy
BioNate Breg is a postdoctoral fellow at Stanford University's Department of Health Policy and at the Palo Alto Veterans Health Administration. He earned his PhD at Carnegie Mellon University and his BA at Tufts University.
His interest in health care providers intersects with questions from labor economics and industrial organization. Nate's current research investigates how providers respond to incentives, how they decide to adopt new technology, and how health care services affect local economies and local health. He is a 2020-2021 recipient of the Fellowship in Digital Health from CMU's Center for Machine Learning and Health.
He previously worked at RTI International on evaluations of government health care initiatives, prospective payment systems, and health care delivery quality measures, employing econometrics and other quantitative methods. His clients included the U.S. Centers for Medicare and Medicaid Services (CMS), the Centers for Disease Control and Prevention (CDC), and the U.S. Health and Human Services Department’s Assistant Secretary for Planning and Evaluation (ASPE).
Research interests: health economics, labor economics, industrial organization, public economics, productivity, reimbursement and regulation, imperfect competition, organizational economics -
Andrew Brooks
Postdoctoral Scholar, Genetics
BioPostdoctoral researcher in the Snyder Lab. My research focuses on the human gut microbiome, and I am involved in multiple multiomic projects investigating how physiological systems through the human body interact across different lifestyles and health states. I perform both wet and dry lab aspects of multiomics analyses, and am involved in two coronavirus research projects including handling of positive SARS-COV-2 samples.
-
Jeffrey Bunker
Postdoctoral Medical Fellow, Infectious Diseases
Fellow in Graduate Medical EducationBioJeffrey Bunker is an infectious diseases physician-scientist, immunologist, and microbiologist. He is currently a clinical fellow in infectious diseases at Stanford University; he previously completed residency training in internal medicine at Stanford University and an M.D. and Ph.D. in immunology at the University of Chicago. Bunker’s research investigates interactions between the microbiome and the immune system, including fundamental questions about how and why certain microbes generate immune responses and how this interplay influences both normal homeostasis and infectious or inflammatory diseases. His clinical interests include microbial pathogenesis, antimicrobial resistance, and the diagnosis and treatment of complex infections.
-
Kristen Burda
Postdoctoral Scholar, Psychiatry
BioKristen Faye Burda is a postdoctoral fellow in the Department of Psychiatry and Behavioral Sciences at the Stanford University School of Medicine. She provides psychotherapeutic interventions to promote sleep health in the Sleep Health and Insomnia Program and is engaged in related research. Dr. Burda's professional interests also include post-traumatic stress and post-traumatic growth, and she seeks to understand the intersection between sleep disorders and post-traumatic hyperarousal and emotional distress. She utilizes and aims to develop digital tools to accessibly and effectively facilitate psychological well-being.
-
Austen Brooks Casey
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
BioAusten Brooks Casey, PhD, is a postdoctoral scholar in the Department of Anesthesiology, Perioperative and Pain Medicine (advisor: Boris Dov Heifets, MD, PhD). He originates from western North Carolina, and has had a long-standing interest in drug discovery for major depression and schizophrenia, which was invigorated by initial coursework in organic chemistry and biochemistry. Austen trained at Northeastern University (advisor: Raymond G. Booth, PhD) where he studied the medicinal chemistry and pharmacology of novel ligands targeting serotonergic G protein-coupled receptors. Currently, he is investigating neural circuits activated by psychedelic drugs, with the long-term goal of using modern techniques in neuroscience to complement drug design efforts toward the development of novel antidepressant and antipsychotic medications.
-
Arianne Caudal
Postdoctoral Scholar, Cardiovascular Institute
BioDr. Arianne Caudal is a postdoctoral fellow at the Stanford Cardiovascular Institute with research interests in cardiac metabolism, disease modeling, and drug discovery. Dr. Caudal received her PhD in Biochemistry from the University of Washington, after conducting thesis work on mitochondrial metabolism and protein-protein interactions in the heart.
-
Katie Cederberg
Postdoctoral Scholar, Psychiatry
BioDr. Cederberg's primary research interests focus on studying the efficacy and effectiveness of exercise for managing symptoms of restless legs syndrome (RLS) and co-occurring conditions (e.g., periodic limb movements, insomnia). She is currently an NHLBI T32 funded Postdoctoral Scholar in the Mignot Lab, where she she devotes her time to conducting research aimed at better understanding the relationship among genetics, proteomics, and the presence of and severity of symptoms related to RLS. Her current research is interested in patient's personal experiences with exercise and RLS as well as the relationship between exercise and proteomic biomarkers of RLS. She received her PhD in Rehabilitation Science from the University of Alabama at Birmingham in December 2020, wherein her dissertation utilized a series of methodological approaches to comprehensively examine the relationship between physical activity and RLS in adults with MS. She plans to utilize her experience and training to develop a line of research for informing exercise prescription parameters specifically for managing symptoms of RLS.
-
Antara Chakravarty
Postdoctoral Scholar, Microbiology and Immunology
BioAntara is a Postdoc in Dr. Priscilla Yang's Lab, where she is exploring small molecule-based targeted protein degradation as an antiviral strategy against structural proteins of flaviviruses. She is also keenly interested in understanding the mechanistic details of virus-induced changes in membrane lipid composition of infected cells, for which she is using hepatitis C virus replicase complex as a model system. Antara received training in molecular virology during her doctoral work in Dr. ALN Rao's Lab at the University of California-Riverside. There she discovered key implications of viral capsid dynamics in the pathogenicity and infectivity of multipartite bromoviruses.
-
Varuna Chander
Postdoctoral Scholar, Genetics
Temp - Non-Exempt, Office of Technology Licensing (OTL)BioDr. Varuna Chander is a postdoctoral researcher specializing in genomics and bioinformatics. She holds a BTech and Masters in Industrial Biotechnology, and has experience in early-stage sequencing product development for 7 years. Dr. Chander earned her PhD in Genetics and Genomics from the Human Genome Sequencing Center at Baylor College of Medicine, where she was awarded the NLM Biomedical Informatics and Data Science Fellowship for three years. Her research focused on investigating the molecular causes of rare diseases and also the relationship between somatic mutations in blood and cardiovascular disease risk. Alongside her research, Dr. Chander collaborated on projects employing computational methods to examine the role of structural variation in genetic diseases. Currently, she works with Michael Snyder to study the genomic basis of complex human diseases using multi-omics and machine learning approaches.
-
Paulami Chatterjee
Postdoctoral Scholar, Pulmonary and Critical Care Medicine
Current Research and Scholarly InterestsMy research involves studying the pathogenic mechanisms underlying the host-pathogen interaction in pulmonary diseases. I am particularly interested in exploring transcriptomic and proteomic changes in Cystic Fibrosis and Asthma patients who develop severe allergic inflammation due to fungal hypersensitivity. Complete understanding of these interaction will help us identify significant fungal virulence factors and help us define clinically relevant targets for therapeutic use.
-
Jingxun Chen
Postdoctoral Scholar, Genetics
Current Research and Scholarly InterestsUnderstand the molecular impact of sexual interaction on vertebrate organ aging
-
Ming Li (Estella) Chen
Postdoctoral Scholar, Cardiovascular Medicine
BioI am an MD from Chung Shan Medical University, Taiwan. Before coming to Stanford, I obtained my MS degree in epidemiology at Harvard T.H. Chan School of Public Health, Boston, MA, where I completed graduate training in clinical, pharmacologic, and genetic epidemiology, and pursued advanced skills in biostatistics and causal inference.
My past research focused on real-world epidemiology studies using patient registries and national health insurance databases to elucidate the predictors or risk factors of immunologic diseases. For my graduate study, I conducted pharmacoepidemiology studies using electronic health record (EHR) data to elucidate the predictors of anti-drug antibodies development and its correlation to autoimmunity, to identify the generation of immunogenicity that may impact the effectiveness of monoclonal antibody therapies in individuals with autoimmune diseases. I gained experience in genetic data manipulation to investigate polymorphisms in response to monoclonal antibody therapies in asthma patients.
At Stanford, I am involved in research on the identification of molecular determinants of cardiometabolic diseases.
